Eunan is an experienced biopharmaceutical executive.
Most recently he co-founded Adapt Pharma, a leader in opioid overdose treatment, where he served as its Chief Operating Officer until its sale to Emergent BioSolutions. Previously he co-founded Azur Pharma, a CNS and Women’s Health Pharmaceutical business, and served as its President until it merged with Jazz Pharmaceuticals. He subsequently led strategy and corporate development at Jazz.
Earlier in his career, Eunan was Vice President of business development at King Pharmaceuticals (acquired by Pfizer) and Strategy at Elan Corporation.
Eunan is an accountant by profession and trained at KPMG. His board memberships include AixThera, ALSHC and Avectas.
He received a Bachelor of International Commerce and French from University College Dublin, Ireland.